Pranjal Gambhir Joins Lazard as Head of Medical Technology
Get Alerts LAZ Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 4.7%
Revenue Growth %: +12.5%
Join SI Premium – FREE
In this role, Pranjal will lead coverage of Medical Technology companies, advising clients on strategy and corporate development transactions across the sector.
"Pranjal has broad and deep experience across the Medical Technology sector, and his arrival deepens the coverage we can offer clients," said
Pranjal joins Lazard from Citi, where he was most recently Managing Director covering Medical Technology companies across multiple sub-sectors. He spent 20 years at Citi across various roles in
"The Medical Technology sector continues to evolve rapidly, creating both opportunity and complexity for clients," said
Pranjal earned his MBA from the Indian School of Business and Bachelor of Commerce from Delhi University.
Founded in 1848, Lazard is the preeminent financial advisory and asset management firm, with operations in
Media Relations
+1 212-632-6571
[email protected]
+1 212-632-6880
[email protected]
Investor Relations
+1 212-632-1564
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/pranjal-gambhir-joins-lazard-as-head-of-medical-technology-302891151.html
SOURCE Lazard
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hengrui Pharma and Novo Enter Exclusive License Agreement for Once-Weekly Oral GLP-1/GIP Dual Receptor Agonist HRS-1596
- ALS Network Celebrates Final Congressional Passage of ACT for ALS Reauthorization Act
- Pine Labs Extends Five-Year Technology Partnership With Woolworths Group
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Citi, LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share